Examination Report |
1 | Additional Representation Sheet | 03 May 2016 |
1 | TM-1 | 03 May 2016 |
2 | Additional Representation Sheet | 03 May 2016 |
2 | TM-1 | 03 May 2016 |
3 | Reply to Exam Report (MIS-R) | 06 Feb 2017 |
4 | TM-O(NOTICE OF OPPOSITION) | 22 Jan 2018 |
5 | Journal Copy | 22 Jan 2018 |
1 | Opposition Notice | 6291140 | 2760953 | 02 May 2018 |
The application for Lortinib was made on 03 May 2016.
The trademark applicant for Lortinib is RPG LIFE SCIENCES.
Lortinib is applied in class(es) 5.
Application for Lortinib is on Opposed stage.
Application Id allotted to Lortinib is 3248905.
Lortinib filed with the Intellectual property office as a WORD.